Attention Deficit Disorder with Hyperactivity

The grounding supports a major genetic component and a multifactorial inheritance pattern. Genome-wide studies identify multiple risk loci and risk genes, indicating that the disorder is not caused by a single factor. The literature also implicates common and rare variants affecting early brain development.

The disorder is associated with genetic variation enriched in genes expressed during early brain development and with brain-specific neuronal subtypes, including midbrain dopaminergic neurons. Co-studied mechanisms include cognition, emotional regulation, anxiety, and depression, consistent with broad effects on neurobehavioral function. The literature also supports a polygenic architecture with contributions from both common and rare variants.

Male sex is reported as more frequent than female sex. Childhood onset is intrinsic to the disorder, and persistence into adulthood occurs in a minority. Genetic susceptibility is a major risk factor, with multiple inherited variants contributing to liability.

The grounding supports therapy and drug therapy as covered aspects, but it does not specify particular treatment modalities or drug classes. Therefore, the standard of care cannot be stated from the supplied material. null